Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Proc Natl Acad Sci U S A ; 101(15): 5577-82, 2004 Apr 13.
Article in English | MEDLINE | ID: mdl-15031428

ABSTRACT

In most eukaryotic cells, the C-terminal amino acid of alpha-tubulin is aromatic (Tyr in mammals and Phe in Saccharomyces cerevisiae) and is preceded by two glutamate residues. In mammals, the C-terminal Tyr of alpha-tubulin is subject to cyclic removal from the peptide chain by a carboxypeptidase and readdition to the chain by a tubulin-Tyr ligase. There is evidence that tubulin-Tyr ligase suppression and the resulting accumulation of detyrosinated (Glu) tubulin favor tumor growth, both in animal models and in human cancers. However, the molecular basis for this apparent stimulatory effect of Glu tubulin accumulation on tumor progression is unknown. Here we have developed S. cerevisiae strains expressing only Glu tubulin and used them as a model to assess the consequences of Glu tubulin accumulation in cells. We find that Glu tubulin strains show defects in nuclear oscillations. These defects are linked to a markedly decreased association of the yeast ortholog of CLIP170, Bik1p, with microtubule plus-ends. These results indicate that the accumulation of Glu tubulin in cells affects microtubule tip complexes that are important for microtubule interactions with the cell cortex.


Subject(s)
Cell Nucleus Structures/metabolism , Glutamic Acid/genetics , Saccharomyces cerevisiae Proteins/biosynthesis , Saccharomyces cerevisiae/metabolism , Tubulin/biosynthesis , Tubulin/genetics , Amino Acid Substitution , Benomyl/pharmacology , Cell Nucleus Structures/genetics , Fluorescence , Genotype , Microscopy, Video , Microtubules/metabolism , Mitosis , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Spindle Apparatus/metabolism , Tubulin/chemistry
2.
Eur J Pharmacol ; 345(3): 323-31, 1998 Mar 26.
Article in English | MEDLINE | ID: mdl-9592033

ABSTRACT

We characterized neutral endopeptidase activity and protein in the three aortic layers and in corresponding cultured primary cells. Neutral endopeptidase was expressed in all three layers of rat aorta with higher protein level and activity in the adventitia than in the media and intimal endothelium. Neutral endopeptidase was also found in primary cultured fibroblasts, smooth muscle and endothelial cells derived from the corresponding layers. Neutral endopeptidase activity and protein were higher in the fibroblasts and smooth muscle cells than in endothelial cells. Neutral endopeptidase inhibition prevented atrial natriuretic peptide (ANP) degradation in endothelial and smooth muscle cells. It potentiated ANP-stimulated cyclic GMP production in these cells. Neutral endopeptidase inhibition also reduced bradykinin degradation and potentiated bradykinin-stimulated release of arachidonic acid in fibroblasts and endothelial cells. Our data demonstrate the presence and functional activity of neutral endopeptidase in all three cell layers of rat aorta as well as in primary cells of the vessel. The data suggest that local concentrations of vasoactive peptides in the vessel wall might be regulated by the neutral endopeptidase cleavage pathway in the immediate vicinity of their target cells.


Subject(s)
Muscle, Smooth, Vascular/enzymology , Muscle, Smooth, Vascular/physiology , Neprilysin/metabolism , Peptides/physiology , Animals , Aorta, Thoracic/cytology , Aorta, Thoracic/enzymology , Aorta, Thoracic/physiology , Arachidonic Acid/metabolism , Atrial Natriuretic Factor/metabolism , Atrial Natriuretic Factor/pharmacology , Bradykinin/metabolism , Bradykinin/pharmacology , Cell Separation , Cyclic GMP/biosynthesis , Electrophoresis, Polyacrylamide Gel , Male , Muscle, Smooth, Vascular/cytology , Neprilysin/chemistry , Polymerase Chain Reaction , RNA/analysis , RNA/isolation & purification , Rats , Rats, Wistar , Signal Transduction/drug effects
3.
Am J Physiol ; 272(6 Pt 1): C1836-43, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9227412

ABSTRACT

We recently reported that neutral endopeptidase (NEP) expression on renal vascular smooth muscle cells (VSMC) was downregulated in the presence of serum. Here we examine the role of epidermal growth factor (EGF) and transforming growth factor-beta 1 (TGF-beta) in this downregulation and the consequences of the changes in NEP activity on their mitogenic effects. EGF inhibited NEP activity, whereas TGF-beta was stimulatory. Expression of the enzyme was studied by measuring the binding of [125I]RB-104, a specific NEP inhibitor, and the fluorescence intensity of NEP-labeled cells. Both parameters were decreased by EGF and were increased by TGF-beta. NEP mRNA expression in EGF-treated cells was reduced after 48 h. In contrast, it was increased in TGF-beta-treated cells. Interestingly, NEP inhibition influenced the mitogenic effect of EGF. Indeed, thiorphan, an NEP inhibitor, and an anti-NEP antibody decreased EGF-dependent [3H]thymidine incorporation and cell proliferation by approximately 50%. TGF-beta had no effect on VSMC growth. These results indicate that EGF but not TGF-beta participates in the downregulatory potency of serum on NEP expression in VSMC. They also demonstrate that the full effect of EGF on VSMC proliferation depends on intact NEP activity.


Subject(s)
Epidermal Growth Factor/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Kidney Cortex/blood supply , Muscle, Smooth, Vascular/enzymology , Neprilysin/biosynthesis , Transforming Growth Factor beta/pharmacology , Animals , Cell Division/drug effects , Cell Membrane/enzymology , Cells, Cultured , Flow Cytometry , Iodobenzenes/metabolism , Kinetics , Male , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Protease Inhibitors/metabolism , Rabbits , Time Factors , Transcription, Genetic/drug effects , gamma-Aminobutyric Acid/analogs & derivatives , gamma-Aminobutyric Acid/metabolism
4.
Eur J Clin Invest ; 26(11): 1011-7, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8957208

ABSTRACT

A previous epidemiological study has reported the elevation of a serum metalloendopeptidase activity for underground coalminers exposed to chronic inhalation of coal mine dust particles. In this work, we have unambiguously characterized this activity as neutral endopeptidase (EC 3.4.24.11) using five different criteria. The apparent molecular weight of 100,000 g mol-1 calculated for the serum peptidase using Western blots or direct binding of the neutral endopeptidase 24.11 inhibitor [125I]-RB104 to the enzyme in acrylamide gels, suggests that the soluble form of this ectoenzyme is not generated by a post-translational cleavage of the membrane-bound form, as is the case for the closely related ectoenzyme, angiotensin-converting enzyme. The circulating endopeptidase very likely results from a shedding process. The increase in serum neutral endopeptidase 24.11 activity of underground miners compared with surface miners (5.7-fold), P < 0.01) is not correlated with systemic inflammation parameters, but seems to reflect the chronic pulmonary inflammatory state induced by coalmine dust exposure, and so may be a marker of lung injury.


Subject(s)
Coal Mining , Neprilysin/blood , Pneumoconiosis/blood , Pneumoconiosis/epidemiology , Coal/adverse effects , Dust , Humans , Immunoblotting , Neprilysin/antagonists & inhibitors , Pneumoconiosis/enzymology , Protease Inhibitors/pharmacology , Solubility , Thiorphan/analogs & derivatives , Thiorphan/pharmacology
5.
Anal Biochem ; 241(1): 120-7, 1996 Oct 01.
Article in English | MEDLINE | ID: mdl-8921173

ABSTRACT

The light chain of tetanus toxin (TeNT-L chain), endowed with a zinc metalloendopeptidase activity, cleaves specifically the vesicle-associated membrane protein (VAMP), also called synaptobrevin, at a single peptide bond (Gln76-Phe77), resulting in the blockade of neuroexocytosis. The 50-mer synaptobrevin peptide S 39-88, synthesized by solid-phase peptide synthesis, was determined to be the minimum substrate of TeNT still notably hydrolyzed by TeNT-L chain. In this peptide, Tyr88 was substituted by the highly fluorescent amino acid (L) pyrenylalanine (Pya) which was synthesized in good yields by an enantioselective method. The fluorescent substrate [Pya88] S 39-88 was cleaved four times more rapidly by TeNT-L chain than S 39-88 (kcat/Km = 9635 and 2455 M-1.min-1, respectively). One of the two metabolites formed by the action of TeNT L chain, [Pya88] S 77-88, was easily separated from the substrate in one step using Sep-Pak Vac C18 cartridges and its concentration quantified by fluorescence. This novel enzymatic assay, which could be easily extended to other clostridial neurotoxins, is a major improvement in term of sensitivity and time saving, compared to currently used methods (SDS-PAGE, HPLC). It lends itself readily to automation for large-scale screening of selective and potent inhibitors of these neurotoxins which remain to be developed.


Subject(s)
Biological Assay , Membrane Proteins/metabolism , Metalloendopeptidases/analysis , Tetanus Toxin/analysis , Amino Acid Sequence , Fluorescence , Humans , Membrane Proteins/genetics , Metalloendopeptidases/metabolism , Molecular Sequence Data , R-SNARE Proteins , Sensitivity and Specificity , Substrate Specificity , Tetanus Toxin/metabolism
6.
Anal Biochem ; 219(1): 87-95, 1994 May 15.
Article in English | MEDLINE | ID: mdl-8059959

ABSTRACT

A novel fluorogenic peptide, dansyl-Gly-(p-NO2) Phe-beta Ala (DGNPA), was synthesized as a selective substrate for neutral endopeptidase 24.11, an enzyme involved in enkephalin and atrial natriuretic peptide degradation and a marker of differentiation (CD10) on the surface of lymphohematopoietic cells. Cleavage of the substrate Gly-(p-NO2)Phe amide bond leads to an increase in fluorescence related to the disappearance of the intramolecular quenching of the dansyl fluorescence by the nitrophenyl residue. This new fluorogenic substrate is an improvement over the commercially available dansyl-D-Ala-Gly-(p-NO2)Phe-Gly, as the Gly4 residue of the latter has been replaced by a beta-alanine, therefore eliminating a residual sensitivity of the peptide toward angiotensin converting enzyme. Moreover, deletion of the D-Ala2 residue was shown to increase the quenching efficiency, thus raising the sensitivity of the assay, which was further improved by stopping the reaction with dioxane. The present substrate has improved affinity (Km = 37 microM, V = 0.72 mumol min-1 mg protein-1), selectivity, and sensitivity over its precursor and was used in automated assays using 96-well microplates and a fluorescence plate reader.


Subject(s)
Brain/enzymology , Dansyl Compounds/chemical synthesis , Kidney/enzymology , Neprilysin/analysis , Oligopeptides/chemical synthesis , Amino Acid Sequence , Animals , Biomarkers , Cell Membrane/enzymology , Indicators and Reagents , Molecular Sequence Data , Rabbits , Spectrometry, Fluorescence/methods , Spectrophotometry, Ultraviolet/methods , Substrate Specificity
7.
Proc Natl Acad Sci U S A ; 89(14): 6388-92, 1992 Jul 15.
Article in English | MEDLINE | ID: mdl-1385873

ABSTRACT

Neutral endopeptidase 24.11, also known as the common acute lymphoblastic leukemia antigen, is a zinc metallopeptidase involved in the inactivation of biologically active peptides, such as the enkephalins and atrial natriuretic peptide. The highly potent radiolabeled inhibitor 2-((3-[125I]iodo-4-hydroxy)phenylmethyl)-4-N-[3-(hydroxyamino-3-oxo-1- phenylmethyl)propyl]amino-4-oxobutanoic acid ([125I]RB104; Ki = 30 pM) has been developed for the enzyme. [125I]RB104 is highly specific, its Ki for another widely distributed zinc peptidase, angiotensin-converting enzyme, being 15 microM. In binding studies using rat brain slices, [125I]RB104 was shown to have a high affinity (Kd = 300 +/- 20 pM) and high specific binding at the Kd concentration (90%). With rat brain homogenates the Kd of [125I]RB104 was 26.8 +/- 0.9 pM, close to the kinetically derived Kd, 7.0 +/- 0.8 pM. Using the inhibitor, we have developed a simple, rapid, and quantitative technique to detect low nanogram quantities of the endopeptidase directly from tissue extracts after SDS/PAGE. The method has been used to show the presence of low quantities of the enzyme in rabbit bone marrow. Apart from its sensitivity, "inhibitor gel electrophoresis" using [125I]RB104 has the advantage over immunohistochemical methods of being able to label the enzyme in all tissues and species. It will therefore be of great value in determining the exact role of this important regulatory peptidase in a number of biological systems. Moreover, this one-step characterization of neutral endopeptidase 24.11 could be extended to other zinc metallopeptidases such as angiotensin-converting enzyme or collagenases, and inhibitors with affinities as high as RB104 could open the way to visualization of zinc metallopeptidases in different tissues by electron microscopy.


Subject(s)
Iodobenzenes/pharmacology , Neprilysin/antagonists & inhibitors , Protease Inhibitors , gamma-Aminobutyric Acid/analogs & derivatives , Animals , Antigens, Differentiation/metabolism , Antigens, Neoplasm/metabolism , Cell Membrane/enzymology , Electrophoresis, Polyacrylamide Gel/methods , Kidney/enzymology , Kinetics , Rabbits , gamma-Aminobutyric Acid/pharmacology
8.
Mol Pharmacol ; 41(4): 609-14, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1533267

ABSTRACT

Neutral endopeptidase 24.11 (EC 3.4.24.11) inactivates atrial natriuretic peptide by cleaving the hormone between Cys7 and Phe8, and inhibitors of the enzyme have consequent natriuretic and diuretic properties. The in vivo sites of degradation of this peptide by the zinc-metallopeptidase, however, remain to be established. Because an endopeptidase-24.11-like activity has recently been reported in the rat mesenteric artery, we have further investigated the degradation of atrial natriuretic peptide in vascular tissue. Endopeptidase-24.11 activity was detected in solubilized membrane preparations from rat and rabbit vascular tissue, using [3H]D-Ala2-leucine enkephalin as substrate, and both rabbit and rat aorta preparations were also found to cleave atrial natriuretic peptide between Cys7 and Phe8. In both cases, hydrolysis was inhibited by neutral endopeptidase inhibitors, with Ki values close to their Ki values for the pure enzyme. In preparations of rabbit aorta denuded of endothelium by saponin treatment, the hydrolysis of the Gly3-Phe4 bond of [3H]D-Ala2-leucine enkephalin and the Cys7-Phe8 bond of atrial natriuretic peptide was reduced by greater than 90%. The high performance liquid chromatography method used to follow the degradation of atrial natriuretic peptide differed from previously published procedures, in that samples to be injected were first treated with excess dithiothreitol to reduce the Cys7-Cys23 disulfide bridge. This facilitated the separation of the intact peptide and its metabolites. The presence of the 94-kDa neutral endopeptidase in rabbit aortic tissue was definitively established using a new potent 125I-labeled inhibitor, [125I]RB104 [2-[(3-[125I]iodo-4-hydroxy)phenylmethyl]-4-N-[3- hydroxyamino-3-oxo-1-phenylmethyl propyl]amino-4-oxobutanoic acid] (Ki, 30 pM), which selectively labeled the enzyme after sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the membrane preparations. Therefore, despite its low concentrations in the vasculature, the presence of endopeptidase-24.11 almost exclusively in endothelial tissue suggests that the enzyme is ideally localized to inactivate circulating atrial natriuretic peptide.


Subject(s)
Atrial Natriuretic Factor/antagonists & inhibitors , Endothelium, Vascular/drug effects , Neprilysin/pharmacology , Amino Acid Sequence , Animals , Autoradiography , Chromatography, High Pressure Liquid , Electrophoresis, Polyacrylamide Gel , Endothelium, Vascular/metabolism , Enkephalin, Leucine-2-Alanine/metabolism , Humans , In Vitro Techniques , Molecular Sequence Data , Neprilysin/antagonists & inhibitors , Rats , Sulfhydryl Compounds/pharmacology , Thiorphan/pharmacology
9.
J Pharmacol Exp Ther ; 261(1): 181-90, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1560364

ABSTRACT

N-([(R,S)-2-benzyl-3[(S)(2-amino-4-methylthio)butyl dithio]-1-oxopropyl)-L-phenylalanine benzyl ester (RB101) is the first systemically active prodrug generating through a biologically dependent cleavage of the disulfide bond the potent (S)2-amino-1-mercapto-4-methylthio butane (aminopeptidase N) (IC50 = 11 nM) and N-[(R,S)-2-mercapto-methyl-1-oxo-3-phenylpropyl]-L-phenylalanine (neutral endopeptidase) (IC50 = 2 nM) inhibitors (aminopeptidase N). RB101 easily crosses the blood-brain barrier, as shown by the observed complete inhibition of cerebral endopeptidase 24.11 after i.v. injection in mice. The prodrug induces strong, dose-dependent antinociceptive responses in mice after i.v., i.p. or s.c. administration, in the hot plate (ED50 = 9 mg/kg) and phenylbenzoquinone-induced writhing (ED50-3.25 mg/kg) tests in mice, which are currently used in analgesics screening. RB101 is also active in the tail-flick and tail-electric stimulation tests in rats. In contrast, under disulfide forms, the above selective aminopeptidase N or endopeptidase 24.11 inhibitors are inactive after i.v. administration and their association 3 times less potent than RB101 alone. In all the tests used, the pain-alleviating effect of RB101 was suppressed by naloxone, but, except for the tail-flick and the motor response to tail-electric stimulation, not by the delta-selective antagonist naltrindole. The preferential involvement of mu opioid receptors in the analgesic effects of endogenous enkephalins, whose extracellular levels are increased by the two RB101-generated inhibitors, is suggested by the similar apparent pA2 values for RB101-naloxone (pA2: 7.53 +/- 0.046) and DAMGO (mu-selective ligand)-naloxone (pA2: 7.38 +/- 0.049).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Aminopeptidases/antagonists & inhibitors , Analgesia , Analgesics/pharmacology , Disulfides/pharmacology , Neprilysin/antagonists & inhibitors , Phenylalanine/analogs & derivatives , Prodrugs/pharmacology , Analgesics/administration & dosage , Animals , Cell Membrane/drug effects , Chromatography, High Pressure Liquid , Drug Interactions , Enkephalin, Ala(2)-MePhe(4)-Gly(5)- , Enkephalins/pharmacology , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , Injections, Intravenous , Injections, Intraventricular , Injections, Subcutaneous , Male , Mice , Naloxone/pharmacology , Phenylalanine/pharmacology , Prodrugs/administration & dosage , Rats , Rats, Inbred Strains
10.
Int J Pept Protein Res ; 34(3): 246-55, 1989 Sep.
Article in English | MEDLINE | ID: mdl-2574715

ABSTRACT

To further characterize the S'2 subsite of both the neutral endopeptidase (EC 3.4.24.11, NEP) and aminopeptidase N (EC 3.4.11.2, APN), two enzymes physiologically involved in enkephalin metabolism, a new series of hydroxamate inhibitors containing a cyclic amino acid as the P'2 component were synthesized. These amino acids differ by the size of the cycle, the relative position of the functional groups, and their absolute configuration. Highly efficient inhibitors of NEP were obtained whatever the modification on the P'2 component, while for APN inhibition, a cyclic beta-amino acid was preferred. The most active inhibitors contained a trans cyclopentyl beta-amino acid and a cis or a trans cyclohexyl beta-amino acid. When injected intracerebroventricularly in mice, these two latter compounds elicited potent antinociceptive responses on both the jump latency and the fore paw lick times.


Subject(s)
Amino Acids/chemical synthesis , Aminopeptidases/antagonists & inhibitors , Cyclohexanes/chemical synthesis , Cyclopentanes/chemical synthesis , Neprilysin/antagonists & inhibitors , Amino Acids/pharmacology , Analgesics/pharmacology , Animals , CD13 Antigens , Cyclohexanes/pharmacology , Cyclopentanes/pharmacology , Hydroxamic Acids/antagonists & inhibitors , Male , Mice , Rabbits
11.
J Med Chem ; 32(7): 1497-503, 1989 Jul.
Article in English | MEDLINE | ID: mdl-2738884

ABSTRACT

In order to improve the in vivo protection of enkephalins from enzymatic degradation, a new series of inhibitors derived from kelatorphan [HONHCOCH2CH(CH2Ph)CONHCH(CH3)COOH], the first-described complete inhibitor of enkephalin metabolism, were designed by modification of the C-terminal amino acid. The progressive lengthening of the chain of this residue shows that a beta-alanine seems to be the best basic model for the conception of such types of compounds. On the other hand, the methylation of the amide bond, which is well accepted by aminopeptidase N (EC 3.4.11.2) and dipeptidylaminopeptidase, induced a significant loss of affinity for neutral endopeptidase -24.11. Starting from these data, compounds containing a variously substituted beta-alanine residue and corresponding to the general formula HONHCOCH2CH(CH2Ph)CONHCH(R1)CH(R2)COOH were synthesized. All these molecules inhibit neutral endopeptidase -24.11 and dipeptidylaminopeptidase in the nanomolar range, and those containing an aromatic chain (compound 7A, R1 = CH2Ph,R2 = H, and compound 8A, R1 = Ph, R2 = H) inhibit the biologically relevant aminopeptidase N, with IC50's around 10(-8) M. Intracerebroventricular injection in mice of these multienzyme inhibitors produced an efficient and naloxone-reversible analgesic response (hot plate test): compounds 7A and 8A were shown to be more potent than kelatorphan in increasing the jump latency time, in agreement with their in vitro properties, and these new compounds were found to increase the forepaw lick latency, a reflex considered as a typical morphine response.


Subject(s)
Analgesics , Dipeptides/pharmacology , Enkephalins/antagonists & inhibitors , Animals , Enkephalins/metabolism , Male , Mice
12.
Int J Pept Protein Res ; 33(2): 146-53, 1989 Feb.
Article in English | MEDLINE | ID: mdl-2707969

ABSTRACT

The retro-inversion of the amide bond in kelatorphan and analogs, the first series of complete inhibitors of enkephalin metabolism, led to compounds highly efficient only against the neutral endopeptidase 24-11 (NEP). In order to increase the recognition of the aminopeptidase N (APN) and dipeptidylaminopeptidase (DAP), without loss of affinity for NEP, the malonyl group of these retro-inhibitors was replaced by diversely substituted succinyl moieties. All the molecules synthesized are highly efficient NEP inhibitors with Ki's in the 0.2-1 nM range, indicating that NEP possesses a relatively large and not very selective S'2 subsite. In contrast, inhibition of DAP activity is crucially dependent on the size and the position of the substituent in the succinyl moiety. Inhibitory potencies in the nanomolar range are obtained with compounds containing a benzyl group in the alpha-position related to the retro amide bond. Finally, a relatively modest inhibition of APN was observed with Ki's in the 0.5-1 microM range for compounds with benzyl or cyclohexyl group in P'2 position. However, these data demonstrate that efficient and complete inhibition of enkephalin degradation can be obtained with hydroxamate dipeptides containing a retro amide bond. The analgesic potency of the most active inhibitors was measured using the hot plate test in mice. Significant antinociceptive responses were obtained but these effects were rather weaker than those expected from the in vitro inhibitory potencies of these compounds on the three enkephalin-degrading enzymes.


Subject(s)
Dipeptides/pharmacology , Enkephalins/antagonists & inhibitors , Neprilysin/antagonists & inhibitors , Animals , Brain/enzymology , Chemical Phenomena , Chemistry , Kidney/enzymology , Rabbits , Rats , Swine
13.
J Med Chem ; 31(9): 1825-31, 1988 Sep.
Article in English | MEDLINE | ID: mdl-2900898

ABSTRACT

Peptide retro-inverso modification was applied to the complete hydroxamate inhibitors of the three zinc metallopeptidases (neutral endopeptidase 24-11 (NEP, EC 3.4.24.11), aminopeptidase N (APN, EC 3.4.11.2), and a dipeptidylaminopeptidase (DAP) involved in the in vitro enkephalin degradation by brain tissues. Compounds corresponding to the general formula RN(OH)CO(CH2)nCH(CH2Ph)NHCOCH(R')COOH (n = 0, 1) were synthesized. In the first series of inhibitors (n = 0), the "retro-inverso" modification induced a large decrease in inhibitory potency for NEP as compared to that of the parent compounds. In contrast, the presence of a methylene group between the hydroxamate and CH alpha in the second series (n = 1) led to derivatives with inhibitory potencies in the nanomolar range, similar to their analogues with a natural amide bond. On the other hand, the retro-inverso modification led to a slight improvement in the inhibition of DAP and APN, in the first series of inhibitors, while the inverse result occurred in the second series. Thus, compounds containing an alpha-amino acid moiety in P'1 position behave as weak inhibitors of the three enzymes, with IC50 values in the micromolar range, and compounds bearing a beta-amino acid moiety in the same position are more specific than the parent compounds for NEP inhibition.


Subject(s)
Aminopeptidases/antagonists & inhibitors , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/antagonists & inhibitors , Hydroxamic Acids/pharmacology , Metalloendopeptidases/antagonists & inhibitors , Animals , Brain/enzymology , CD13 Antigens , Chemical Phenomena , Chemistry , Hydroxamic Acids/chemical synthesis , Kidney/enzymology , Molecular Conformation , Neprilysin , Rabbits , Rats , Stereoisomerism , Structure-Activity Relationship , Swine
14.
Cell Biochem Funct ; 5(2): 113-22, 1987 Apr.
Article in English | MEDLINE | ID: mdl-3495371

ABSTRACT

Rat leukocyte elastase has been purified successively by AH-Sepharose Kappa-elastin affinity chromatography and by ion exchange chromatography on a carboxymethyl Sephadex resin. It has great similarities with human leukocyte elastase in its molecular weight, substrate specificity and inhibitory profile. The effect of rat leukocyte elastase inhibitors in influencing the chemotactic response of rat PMN to fMetLeuPhe has been compared to that of other proteinase inhibitors. The results indicated that oleoyl (Ala)2ProValCH2Cl, a specific inhibitor of human and rat leukocyte elastases and Eglin C, which also inhibits human and rat cathepsin G, are among the powerful inhibitors of rat PMN chemotaxis induced by the formyl oligopeptide. This suggests that these neutral proteinases, in addition to their known participation in connective tissue catabolism, could play a role in PMN locomotion and chemotaxis.


Subject(s)
Chemotaxis, Leukocyte/drug effects , N-Formylmethionine Leucyl-Phenylalanine/antagonists & inhibitors , Pancreatic Elastase/antagonists & inhibitors , Serpins , Animals , Blood Proteins/pharmacology , In Vitro Techniques , Molecular Weight , Neutrophils/enzymology , Pancreatic Elastase/isolation & purification , Proteins/pharmacology , Rats , alpha 1-Antitrypsin
15.
Pathol Biol (Paris) ; 33(4): 281-5, 1985 Apr.
Article in English | MEDLINE | ID: mdl-3892459

ABSTRACT

Evidence is presented showing that elastin(s) influences the interactions between porcine pancreatic elastase and its main plasma inhibitor alpha 1-proteinase inhibitor (e.g. alpha 1 antitrypsin). The rate constant of association (kon) between the proteinase and alpha 1 antitrypsin is decreased from 2.8 10(5) M-1 sec-1 to 1.24 10(5) M-1 sec-1 in presence of 1 mg/ml of insoluble elastin and 0.83 10(5) M sec-1 in presence of the same concentration of alpha-elastin. With both elastins this kon decrease was found concentration dependent indicating that these compounds compete in a similar fashion with alpha 1 AT for the binding of elastase. Such an effect was not observed when elastin(s) was replaced by bovine serum albumin. Experiments were designed as previously published (B. Robert et al. 1974) in order to evaluate the capacity of alpha 1 AT to inhibit preadsorbed elastase on to insoluble elastin and also diffusible protease molecules. It was found that even at concentrations far exceeding the equivalence with elastase, alpha 1 AT was only partially able to inhibit both preadsorbed enzyme (approximately 50 per cent) and diffusible protease (approximately 90 per cent).


Subject(s)
Elastin/metabolism , Pancreatic Elastase/metabolism , alpha 1-Antitrypsin/metabolism , Animals , In Vitro Techniques , Kinetics , Pancreatic Elastase/antagonists & inhibitors , Substrate Specificity , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...